---
title: "escalade"
date: "2024-06-23"
tags:
    - building
---

> ðŸŒ± created from: [[2024-06-23-1l-newtreatment]]

# escalade

ESCALADE: A phase 3 study of acalabrutinib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for patients â‰¤65y with untreated non-germinal center B-cellâ€“like (non-GCB) diffuse large B-cell lymphoma (DLBCL).

